PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2022
CVR: 32478697
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -26,473 and a net result of DKK -27,691 compared with DKK -115,382 the year before. Equity in the 2022 report amounted to DKK 36,564. The solvency ratio was 45.4%.
- Gross Profit
- DKK -26,473
- Profit/Loss
- DKK -27,691
- Equity
- DKK 36,564
- Total Assets
- DKK 80,576
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -26 t. | -28 t. | 37 t. | 0 |
| 2021 | - | -112 t. | -115 t. | 64 t. | 0 |
| 2020 | - | 144 t. | 111 t. | 330 t. | - |
| 2019 | - | 455 t. | 434 t. | 567 t. | - |
| 2018 | - | 211 t. | 211 t. | 133 t. | - |
Official annual report
Keep an eye on PHARMAZAN PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK -112,271, and the net result was DKK -115,382.
About PHARMAZAN PHARMACEUTICALS ApS
PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.